New CELLSEARCH® Circulating Multiple Myeloma Test now a

As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where its CELLSEARCH® technology can enumerate Circulating Multiple Myeloma Cells (CMMCs) for non-invasive monitoring of disease BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Nov. 30, 2021 /PRNewswire/ -- Menarini Silicon Biosystems...

Related Keywords

Italy , Fabio Piazzalunga , Centers For Medicare , Menarini Silicon Biosystems Lab Services , Menarini Group , Laboratory Developed Test , Bus Lab , Medicaid Services , Lab Services , Menarini Silicon Biosystems , Circulating Multiple Myeloma Cells , Silicon Biosystems , Circulating Multiple Myeloma Test , Monoclonal Gammopathy , Undetermined Significance , Smoldering Multiple Myeloma , Huntingdon Valley ,